Vanadium Compounds: Biochemical and Therapeutic Applications

Chapter 1 The chemistry of peroxovanadium compounds relevant to insulin mimesis

Chapter 2 Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents

Chapter 3 Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition

Chapter 4 Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bis peroxovanadium complex

Chapter 5 Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases

Chapter 6 Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis

Chapter 7 Unique and selective mitogenic effects of vanadate on SV40-transformed cells

Chapter 8 Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases

Chapter 9 Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart

Chapter 10 In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals

Chapter 11 The relationship between insulin and vanadium metabolism in insulin target tissues

Chapter 12 Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling

Chapter 13 Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy

Chapter 14 Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes

Chapter 15 Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver

Chapter 16 Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase

Chapter 17 The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases

Chapter 18 Contractile effects of vanadate on aorta rings from virgin and pregnant rats

Chapter 19 In vivo modulation of N-myristoyltransferase activity by orthovanadate

Chapter 20 Regulation and control of glucose overutilization in erythrocytes by vanadate

Chapter 21 In vitro and in vivo antineoplastic effects of ortrovanadate

Chapter 22 Membrane — vanadium interaction: A toxicokinetic evaluation

Chapter 23 Increased potency of vanadium using organic ligands

Chapter 24 In vivo effects of peroxovanadium compounds in BB rats

Chapter 25 Long-term antidiabetic activity of vanadyl after treatment withdrawal: Restoration of insulin secretion?

Chapter 26 Long-term correction of STZ-diabetic rats after short-term i.p. VOSO 4 treatment: Persistence of insulin secreting capacities assessed by isolated pancreas studies

Chapter 27 Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats

Chapter 28 Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat

Chapter 29 In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus

Chapter 30 Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulation